Patients with multidrug-resistant HIV currently make up a smaller but still challenging part of the population living with HIV. With careful monitoring and new drugs coming, providers can still help their patients.
“It’s really great that we have a relatively low number of patients with this issue,” said Milena Murray, PharmD, MSc, BCIDP, AAHIVP, an associate professor of pharmacy practice at Midwestern University-Chicago College of Pharmacy, and an HIV/ID clinical